SCHEMBL4048241

SCHEMBL4048241

CN(Cc1ccccc1)c1nc2sc(C(N)=O)c(N)c2c2c1CC(C)(C)C2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.47
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
LIMK1 P53667 2/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
EEF2K O00418 8/20 0.45
IKBKB O14920 2/20 0.43
LMNA P02545 1/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
ATM Q13315 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
CDK8 P49336 1/20 0.42
CDK19 Q9BWU1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5013092 0.89 KDM4E (0.55) HTTKDM4EMAPTLIMK1ALDH1A1
SCHEMBL4049074 0.84 CDK8 (0.50) HTTKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL4052293 0.83 KDM4E (0.53) HTTKDM4EMAPTLIMK1ALDH1A1
SCHEMBL4048237 0.78 ALDH1A1 (0.45) HTTKDM4EMAPTLIMK1ALDH1A1
SCHEMBL4047809 0.76 EEF2K (0.52) HTTKDM4EMAPTEEF2KATM
SCHEMBL4051773 0.75 EEF2K (0.54) HTTKDM4EMAPTEEF2KATM
SCHEMBL4049238 0.73 KDM4E (0.50) KDM4EALDH1A1SMN1; SMN2IKBKBTDP1
SCHEMBL4049422 0.73 PDE4B (0.56) HTTKDM4EMAPTALDH1A1LMNA
SCHEMBL4658096 0.72 CDK8 (0.68) HTTKDM4ELIMK1ALDH1A1SMN1; SMN2
SCHEMBL5015905 0.72 KDM4E (0.64) HTTKDM4EMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819710-B1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES ALMIRALL LAB (ES) 2009-03-11 EP disclosed
US-20090029955-A1 Pyridothienopyrimidine Derivatives ALMIRALL PRODESFARMA S.A. (ES) 2009-01-29 US disclosed
EP-1819710-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2007-08-22 EP disclosed
WO-2006058724-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029955-A1 Pyridothienopyrimidine Derivatives PNPO, PDE4A, DPYD HTT 3871/4885KDM4E 1600/4885MAPT 2618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.